Post by
subaru1i on Jul 06, 2023 11:27am
After J&J spun out Avicanna out of JLABS and IPO, does
anyone know how much of Avicanna went public and how much is still controlled by Johnson&Johnson?
Something could be brewing between AVCN and LABS. AVCN gave access to LABS for the SEDDS proprietary technology in the expanded agreement....launching this year in Canada and international markets (not edibles, etc...pharma applications).
One very KEY point. Before LABS acquired VIVO there were only 2 companies in North America with a Drug Establishment License from Health Canada, basically the same as an FDA pharmaceutical license enabling a company to produce pharmaceutical drug or produce pharmaceutical API's. After LABS completed the VIVO deal, only ONE D.E.L. holder in North America >>>> LABS.
At the last CC, CEO of LABS mentioned they are still open and looking for other M&A opportunities but it has to be a good fit with the company.
I am very LONG in LABS, holding well over 1 million shares...disclosure.
LABS did NOT issue a corresponding press release on the expanded agreement with AVCN.
I am thinking that there could be an iron in the fire on a deal between LABS and AVCN as an additional merger or acquisition by LABS because for AVCN. The synergies, imho, are enormous for both.
Comment by
subaru1i on Jul 08, 2023 9:38am
https://stockhouse.com/companies/bullboard/t.labs/medipharm-labs-corp?postid=35531981 There's always 2 sides to a $coin$.